DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hurst S, Ryan AM, Ng CK et al.
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin®).
BioDrugs 2014;
28: 451-459
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.